MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
Humana Book Value 2011-2025 | HUM
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value Humana
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.4 B | 16.3 B | 15.4 B | 16.1 B | 13.7 B | 12 B | 10.2 B | 9.84 B | 10.7 B | 10.3 B | 9.65 B | 9.32 B | 8.85 B | 8.06 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.4 B | 8.06 B | 11.9 B |
Quarterly Book Value Humana
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18.6 B | 18.3 B | 17.8 B | 17.6 B | 16.7 B | 16.2 B | 17 B | 16.9 B | 16.6 B | 15.4 B | 16.3 B | - | 15.3 B | 16.1 B | 16.3 B | 14.8 B | 14.2 B | 13.7 B | 13.7 B | 13.7 B | 13.7 B | 12 B | 12 B | 12 B | 12 B | 10.2 B | 10.2 B | 10.2 B | 10.2 B | 9.84 B | 9.84 B | 9.84 B | 9.84 B | 10.7 B | 10.7 B | 10.7 B | 10.7 B | 10.3 B | 10.3 B | 10.3 B | 10.3 B | 9.65 B | 9.65 B | 9.65 B | 9.65 B | 9.32 B | 9.32 B | 9.32 B | 9.32 B | 8.85 B | 8.85 B | 8.85 B | 8.85 B | 8.06 B | 8.06 B | 8.06 B | 8.06 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 18.6 B | 8.06 B | 12.1 B |
Book Value of other stocks in the Health care industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Anthem
ANTM
|
41.4 B | - | -2.32 % | $ 107 B |  USA |
 |
Cigna Corporation
CI
|
41.2 B | $ 276.37 | 0.62 % | $ 75.7 B | USA |
 |
Triple-S Management Corporation
GTS
|
2.41 B | - | 0.28 % | $ 847 M | USA |
 |
Magellan Health, Inc.
MGLN
|
269 M | - | -0.19 % | $ 2.49 B | USA |
 |
Centene Corporation
CNC
|
26.5 B | $ 40.59 | -0.66 % | $ 21.2 B | USA |
 |
CVS Health Corporation
CVS
|
75.7 B | $ 79.55 | 0.15 % | $ 100 B | USA |
 |
Molina Healthcare
MOH
|
4.5 B | $ 166.33 | -1.28 % | $ 9.55 B | USA |
 |
UnitedHealth Group Inc.
UNH
|
103 B | $ 340.29 | -0.45 % | $ 313 B | USA |
 |
NovoCure Limited
NVCR
|
360 M | $ 13.02 | -2.29 % | $ 1.4 B |  Jersey |